CATALYST DOSSIER · UPDATED 2026-11-20
$RCKT
biotech · convergence -10 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $RCKT?
Quantitative
Net Income (CY2026Q2) : $123.2M (+278.8% YoY)
Catalysts
Multi-spoke convergence : 8 convergent signals fired: xbrl_ni, biotech, sec_fda, auto_edgar_fulltext, auto_macro_adp_payrolls
Risks
Position-sizing discipline : Conviction AVOID (-10 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
HON via industrials r=+0.72 sympathetic (score 19)
LVWR via industrials r=+0.72 sympathetic (score 15)
NIQ via tech r=+0.67 sympathetic (score 26)
CCC via tech r=+0.67 sympathetic (score 21)
BZAI via semis r=+0.65 sympathetic (score 4)
FLEX via semis r=+0.65 sympathetic (score 4)
Signals Firing
xbrl_ni biotech sec_fda auto_edgar_fulltext auto_macro_adp_payrolls auto_macro_bls_employment auto_macro_credit_spreads auto_macro_durable_goods
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-07 sec_top_gappers +9.7% +3.7% ✓ hit 2026-10-07 sec_top_moat_emerging +9.7% +3.7% ✓ hit 2026-10-06 sec_clean_gappers +6.5% +2.2% ✓ hit 2026-10-06 sec_top_gappers +6.5% +2.2% ✓ hit 2026-10-06 sec_top_moat_emerging +6.5% +2.2% ✓ hit
Lifetime: 5/5 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket HON via industrials · score 19 LVWR via industrials · score 15 NIQ via tech · score 26 CCC via tech · score 21 BZAI via semis · score 4 FLEX via semis · score 4
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.